Drexel Hill, Pennsylvania Clinical Trials
A listing of Drexel Hill, Pennsylvania clinical trials actively recruiting patient volunteers.
Found 102 clinical trials
TEST Trial-001QA1
Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol
- 0 views
- 29 Jan, 2024
- 1 location
Radiomics Tool for Pulmonary Nodule Risk Stratification
The objective of this pragmatic clinical trial is to determine the real-world effect of a radiomics-based computer-aided diagnosis tool on pulmonary nodule management decisions. We hypothesize that a higher proportion of pulmonary nodules will be appropriately managed when clinicians prospectively use a CAD-based risk stratification strategy to evaluate pulmonary nodules. …
- 0 views
- 11 Jul, 2024
- 1 location
403 trial 1
See protocol section 2 See protocol section 2 See protocol section 2
- 0 views
- 19 Jul, 2024
- 1 location
UPENN Case Test Trial 4 (Do Not Make Any Changes)
UPENN Case Test Trial 4 (Do Not Make Any Changes)
- 0 views
- 24 Apr, 2025
- 1 location
test cancer 54321
See protocol section 2 See <i>protocol</i> section 2 See <b>protocol</b> section 2. <p>this is p tag.</p> <h1>header</h1>
- 0 views
- 20 Feb, 2026
- 1 location
test cancer API Toggle On
See protocol section 2 See protocol section 2 See protocol section 2. this is p tag. header
- 0 views
- 20 Feb, 2026
- 1 location
Study of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate Cancer
Evaluate the safety and tolerability of AMG 509 in adult subjects and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D).
- 0 views
- 16 Feb, 2024
- +3 other locations
Niraparib/TTFields in GBM
Evaluating the efficacy and safety of niraparib and Tumor-Treating Fields (TTFields) in recurrent glioblastoma (GBM).
- 0 views
- 16 Feb, 2024
- 1 location
A Study of SY 5609 a Selective CDK7 Inhibitor in Advanced Solid Tumors
This is a dose escalation study and will be the first to administer SY-5609 alone to humans with select advanced solid tumors and in combination with Fulvestrant to patients with HR positive, HER2-negative breast cancer.
- 0 views
- 16 Feb, 2024
- +4 other locations
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body
This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …
- 0 views
- 16 Feb, 2024
- +254 other locations